Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 4/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.60 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.60 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.60 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | NQO2 | P16083 | 2/20 | 0.54 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31436022 | 0.91 | MAPT (0.75) | POLBMAPTKMT2AMEN1ABCB1 | |
| SCHEMBL1934668 | 0.91 | MAPT (0.75) | POLBMAPTKMT2AMEN1ABCB1 | |
| SCHEMBL9479960 | 0.89 | MAPT (0.79) | POLBMAPTKMT2AMEN1ABCB1 | |
| SCHEMBL9479267 | 0.86 | MAPT (0.85) | POLBMAPTKMT2AMEN1HSD17B10 | |
| SCHEMBL20631546 | 0.85 | MAPT (0.66) | POLBMAPTKMT2AMEN1HSD17B10 | |
| SCHEMBL1901172 | 0.83 | ALDH1A1 (0.76) | POLBMAPTKMT2AMEN1HSD17B10 | |
| SCHEMBL31312483 | 0.81 | MPO (0.76) | POLBMAPTKMT2AMEN1ABCB1 | |
| SCHEMBL5078720 | 0.80 | MAPT (0.63) | POLBMAPTKMT2AMEN1HSD17B10 | |
| SCHEMBL5081832 | 0.80 | MAPT (0.63) | POLBMAPTKMT2AMEN1HSD17B10 | |
| SCHEMBL19501805 | 0.80 | KMT2A (0.81) | POLBMAPTKMT2AMEN1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070282076-A1 | Transition Metal Carbene Complexes Embedded in Polymer Matrices for Use in Oleds | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-06 | — | — | US | disclosed |
| US-20070282076-A1 | Transition Metal Carbene Complexes Embedded in Polymer Matrices for Use in Oleds | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070282076-A1 | Transition Metal Carbene Complexes Embedded in Polymer Matrices for Use in Oleds | OCIAD1, OCIAD2, PPID | POLB 687/4885MAPT 525/4885KMT2A 3145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.